Pre-operative Window of Opportunity Study of the Effects of Atovaquone on Hypoxia in Non-small Cell Lung Carcinoma

Trial Profile

Pre-operative Window of Opportunity Study of the Effects of Atovaquone on Hypoxia in Non-small Cell Lung Carcinoma

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs Atovaquone (Primary)
  • Indications Pneumocystis pneumonia
  • Focus Pharmacodynamics
  • Acronyms ATOM
  • Most Recent Events

    • 12 Apr 2017 Planned End Date changed from 1 Nov 2019 to 1 Feb 2019.
    • 21 Jun 2016 Status changed from not yet recruiting to recruiting.
    • 22 Feb 2016 Planned End Date changed from 1 Oct 2019 to 1 Nov 2019 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top